Medifast (NYSE:MED) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?

Medifast Inc (NYSE:MED - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $13.58 and traded as high as $14.06. Medifast shares last traded at $13.83, with a volume of 91,073 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a "sell (d)" rating on shares of Medifast in a report on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Reduce" and an average target price of $16.50.

Medifast Stock Down 0.9%

The company has a 50-day moving average price of $13.77 and a 200-day moving average price of $13.58. The company has a market capitalization of $151.99 million, a price-to-earnings ratio of 43.22 and a beta of 0.85.

Medifast (NYSE:MED - Get Free Report) last announced its earnings results on Monday, August 4th. The specialty retailer reported $0.04 earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.26. The firm had revenue of $105.56 million during the quarter, compared to the consensus estimate of $96.10 million. Medifast had a return on equity of 2.00% and a net margin of 0.76%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. Equities analysts expect that Medifast Inc will post 0.51 EPS for the current fiscal year.

Institutional Trading of Medifast

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Peapod Lane Capital LLC acquired a new stake in Medifast in the 1st quarter worth $933,000. GAMMA Investing LLC grew its position in Medifast by 3,207.2% during the first quarter. GAMMA Investing LLC now owns 3,208 shares of the specialty retailer's stock worth $43,000 after buying an additional 3,111 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Medifast by 132.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock worth $3,580,000 after purchasing an additional 151,434 shares in the last quarter. Acadian Asset Management LLC grew its holdings in shares of Medifast by 41.5% during the 1st quarter. Acadian Asset Management LLC now owns 385,723 shares of the specialty retailer's stock worth $5,193,000 after purchasing an additional 113,111 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Medifast during the 1st quarter worth approximately $407,000. 95.51% of the stock is currently owned by institutional investors and hedge funds.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.